[CLINICAL AND ELECTROPHYSIOLOGICAL EXPERIMENTATION WITH A NEW MONOAMINE OXIDASE INHIBITOR: CP 603].
D000437:Alcoholism; D000928:Antidepressive Agents; D000959:Antihypertensive Agents; D003863:Depression; D003866:Depressive Disorder; D004569:Electroencephalography; D004827:Epilepsy; D004833:Epilepsy, Temporal Lobe; D006801:Humans; D006834:Hydrazines; D001523:Mental Disorders; D008996:Monoamine Oxidase Inhibitors; D013702:Temporal Lobe
D000928:Antidepressive Agents; D000959:Antihypertensive Agents; D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors
ALCOHOLISM; ANTIDEPRESSIVE AGENTS; ANTIHYPERTENSIVE AGENTS; DEPRESSION; ELECTROENCEPHALOGRAPHY; EPILEPSY, TEMPORAL LOBE; HYDRAZINES; MENTAL DISORDERS; MONOAMINE OXIDASE INHIBITORS